Monthly Archives: April 2013

The Rise of Specialty Pharmaceuticals

Albert Thigpen

Fact: Specialty pharmaceuticals represented nearly 25 percent of all drug spending last year. By 2018, it’s estimated they’ll account for nearly half of the 100 top-selling medications on the market. With an average cost for a specialty medical therapy hovering around $35,000 to $75,000 per patient per year, this is an area that is getting the attention of top industry players – from biopharma who see the market opportunity to healthcare payors like health plans Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

State of the Biotech Industry: Burrill’s Biotech 2013 Report

Burrill

To open his Super Session at the 2013 BIO International Convention, G. Steven Burrill, CEO of Burrill & Company, injected some humor for the hundreds of attendees in the audience, saying after 45 years in the biotech industry, 27 years authoring the Burrill State-of-the-Industry Report and 20 years of presenting the report at Convention, he was determined to get through 228 slides in 90 minutes. And, he delivered, providing a comprehensive snapshot of the industry Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Ag Biotech: Going on the Offense

Ag Biotech: Going on the Offense

On Wednesday at the BIO International Convention a panel called “Going on the Offense: Proactive Strategies to Reduce Uncertainty” focused on challenges facing agricultural biotech in the social media and regulatory worlds. Moderated by Peter Whitfield of Baker Hostetler, the panelists included David Bartlett of Levick and Geri Edens and Christopher Marraro, both of Baker Hostetler. Peter opened up the discussion by involving the audience in an interactive poll to determine their willingness to eat Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Scientific American Worldview

Scientific American Worldview

The fifth annual edition of Scientific American Worldview explores ongoing challenges and opportunities in the biopharmaceutical industry, including the looming potential of an “innovation cliff.” Many experts believe that biotechnology remains in its infancy, leaving room for growth. The overall volatility makes it difficult to accurately assess trends within individual countries, but the mission of Worldview is to create an increasingly precise picture of the evolution of biotechnology innovation around the world. One of the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Think Organic Farming is Better for the Environment? Think Again.

brookes_pf

The eighth annual Global Impacts Study released this week by PG Economics quantifies the environmental benefits gained from the use of biotech crops. “We’ve seen a significant reduction in the use of chemical insecticides with biotech crops,” said Dr. Cathleen Enright, BIO’s executive vice president for food and agriculture. “Since 1996 and the advent of agricultural biotechnology, farmers growing these crops have switched to more benign herbicides to help control weeds.” Enright adds, “The shift Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,